"I have worked with many consulting companies during my 11 years in the industry, and this was by far the best experience I have had."
— Client, Genentech
"I was very impressed with the level of industry knowledge...It was a pleasure to work with the team."
— Client, Pfizer
"I was somewhat cynical about the use of outside consultants...but Campbell Alliance is one of the few consulting companies that...creates real, value-added deliverables that move the initiative forward."
— Client, Amgen
"Prior to working with Campbell Alliance, I was a devotee of (another firm). You can count me officially as a convert..."
— Client, Valeant
Brand Management
- Market Opportunity Assessment for Oncology Assets
- Rescoping Defined Principles and Processes
- Trade-Off Testing
- Marketing Support
- Pediatric Launch
- Disease Area Segmentation
- Regional Planning-Brand Planning Integration
- US Oncology Launch Playbook®
- Commercial Representation of Core Team Handbook
- Opportunity Assessment Refinement
- Oncology Franchise Integration and Implementation
- Pen Launch Readiness Plan
- Co-Positioning Workshop
- End-of-Phase II Planning
- Chronic and Breakthrough Pain Treatment Flow Model
- Product Strategic Plan
- Appropriate Utilization of Access Solutions
- Competitive Landscape Executive Presentation
- Launch Playbook®
- Lifecycle Management Workshop
- Autoimmune Disease Patient Buying Process
- Global Strategic Plan
- Launch Playbook
- Global Strategic Plan Development
- Slide Library
- Low Volume Launch Playbook
- Pediatric Product Launch
- Oncology Pipeline Commercial Development Team Onboarding Tool
- Go To Market Model
- Internal Commercial Viability Presentation
- Launch Playbook Management
- War Gaming and Launch Management
- Oncology Franchise Integration and Roll-Out
- Autoimmune Product Analog Research
- Pharmaceutical Platform Initiative Phase I
- Market Development Benchmarking
- UK Launch Strategy
- Canadian Launch Playbook®
- Product Hospital Strategy
- Global Commercialization Strategy
- Consolidated Access Launch Playbook
- Medical Affairs Strategy
- Oncology Summit
- Expanded Indication Product Launch Planning and Support
- Endocrinology Portfolio Assessment
- Product Strategy Development
- Launch Playbook®
- Launch Playbook®
- Disease State Education Program: Project Management Support
- Brand Diagnostic
- Launch Management Support
- Brand Diagnostic
- Disease State Key Opinion Leader Profiling
- MSL Utilization and Benchmarking
- Go To Market Model
- Product Launch Playbook
- Product Launch Playbook
- Oncology Market Assessment
- Pain Portfolio Business Plan
- War Gaming and Launch Management
- Launch Playbook Support
- Opportunity Assessment
- Product Analog Case Studies
- Tumor Assessment Framework
- Commercialization Planning Phase II
- Corporate Strategy
- Launch Playbook
- Market Opportunity Assessment
- Market Opportunity Assessment
- Competitive Intelligence Monitoring Capability
- Launch Monitoring
- Launch Transition Plan
- Commercial Planning Phase I
- Winning Oncology Label
- Education Development for Oncology National Accounts
- Key Opinion Leader Plan
- Oncology Brand Book Planning
- Best Practice Sharing for European Markets
- Market Landscape Assessment
- Life Cycle Management Strategy
- Customer Relationship Management Strategy Development and Execution
- Market Shadow Brand Plans and Competitive Gaming Summit
- Canadian Deep Dive for Launch Readiness
- Shadow Brand Plan and Competitive Gaming Exercise
- Launch Playbook
- Launch Playbook and Scenario Planning
- Tumor Specific Validation
- Indication Prioritization
- KOL Strategy Enhancement
- Launch Support Phase II
- KOL Plan Development
- Disease State Market Assessment
- ISPs and Global Summit
- Launch Support
- Program Enhancement
- Therapeutic Oncology Franchise Development
- Disease State Assessment
- Launch Playbook
- Launch Playbook Update
- Product Buying Process
- Customer Satisfaction Program
- Scientific Affairs Roadshow
- US Launch Playbook
- Disease State Opportunity Assessment
- Oncology Pipeline Commercial Team Handbook
- Competitive Gaming
- Shadow Brand Plan and Competitive Gaming
- Opportunity Prioritization
- Global Launch Playbook
- Three-Year Brand Plan
- Health Economics Capability Development
- BioOncology Operations Plan
- Supportive Care Tactical Planning
- Opportunity Assessment
- Target Product Profile Development
- Therapeutic Oncology Franchise Development
- Portfolio Strategy Initiative
- Market Opportunity Assessment
- Competitive Game
- Analog Development
- Brand Planning Process
- Co-Promotion Launch Support
- Product Marketing Strategy
- Commercial Assessment
- Senior Management Presentation
- Winning Oncology Label
- Health Economics Handbook Development
- KOL Plan Development
- US Brand Plan
- Product Concept Development
- Brand Planning
- PMO Commercial Strategy
- Product Launch Playbook
- Product Forecast
- Launch Playbook
- Marketing Cost Estimates
- Corporate Value System
- Patient Flow Model
- EU Launch Playbook
- Target Product Profile Development
- Market Development Strategy
- Product Publication Planning
- Product Management
- Product Co-Pay Assistance Model
- Product Assessment
- Brand Strategy Analysis
- Therapeutic Area Assessment
- Brand Plan Template Development
- US Product Launch Playbook
- European Product Launch Playbook
- Product Launch Playbook for Expanded Indication
- New Product Launch Playbook
- Therapeutic Area Franchise Strategy
- Product Management Support
- Marketing Summit
- Therapeutic Area Franchise Plan
- Project Management Tool
- Two-Year Brand Plan
- Product Commercialization Plan
- Product Development Plan
- Commercial Strategy Phase II
- Patient Assistance Program
- Product Global Strategic Plan
- Product Competitive Game
- Developing Global Strategic Product Plan
- Developing Global Strategic Plan
- Developing Product Launch Strategy for Expanded Indication
- Product Strategic Plan
- Product Launch Management
- Product Canadian Launch Playbook
- Product Opportunity Analysis
- Product Opportunity Analysis
- Product Assessment for Expanded Indication Filing
- Product Launch Support
- Product Launch Support for Expanded Indication
- Product Brand Plan
- Consolidating Market Research
- Analogue Case Studies
- Developing Global Strategic Plan
- Commercial Planning and Product Franchise Strategy
- Product Program Management
- Practice Manager Advisory Board
- New Distribution Model Launch Preparation
- New Indication Launch Preparation
- Metrics Standardization
- Operations Plan Development
- Value Assessment
- Product Market Report
- Oncology Product Launch Managament
- Comprehensive Presentation Development for a Leading Biotech
- Therapeutic Oncology Franchise Strategy
- Launch Planning for a New Indication
- New Product Launch Guidance
- Assessment of Physician Speaker Program
- New Product Commerical Assessment
- Development and Management of Competitive Gaming Summit to Prepare for a New Product Launch
- Development of New Product Planning Processes
- Re-Launch of a Leading Biotech’s Reimbursement Support Services
- Opportunity Assessment
- Operating Plan Development
- Commercial Opportunity Assessment
- Publication Strategy Development
- Reimbursement and Distribution Model Assessment
- Drug Integration into Physician Practices
- Launch Plan Development
- Pipeline Product Launch Plan
- Marketing Tool Development
- Senior Care Products Managers Meeting
- Medical Affairs Team Update
- New Packaging Configuration Launch
- Activity Plan Development
- Development and Communication of Key Vision
- New Product Launch
- Simultaneous Management of Product Launches in the US and Germany
- Expert Product Launch Planning
- Strategic Evaluation Planning
- Development of Advisory Boards to Formulate Pre-Launch Strategy
- Support of a Marketing Team During a Critical Time
- Development of Target Product Profiles for a Portfolio of CNS Compounds
- Support of a Global Commercial Team
- Development of a Life Cycle Management Strategy
- European Market Segmentation Strategy for a GI Product
- Evaluation of a Brand Plan
- Launch Planning and Support for a New Cardiovascular Product
- Development of a Global Commercial Plan
- Maximize the Effectiveness of a Small Medical Affairs Field Force
- Evaluation of Pre-Launch Preparedness
- Assessment of Launch Preparedness
- Planning and Support for a New Product Launch in Multiple European Markets
- Definition of Commercial Requirements for a Development-Stage Product
- Lifecycle Planning Project
- Pediatric Market Assessment for an In-Line Product
- Creation of a Development Plan for a New Product
- Global Launch Planning and Management
- Tactical Marketing Planning
- Enhancement of Market Research and Commercial Analytics Capabilities
- Long-Term Care Strategy
- Development of a Process for Securing Competing Drugs for Comparator Trials
- Comprehensive Brand Plan for a CNS Product
- Launch Planning and Management for a New Biotech Product
- Survey of the Electronic Medical Records Landscape
- Rescue of a New Product Launch
- Marketing Support for a New Biotech Product
- Pre-Launch Strategy Development for a New Biotech Product
- Pre-Launch Marketing Plan for a New Allergy/Respiratory Medication
- Benchmarking of Pharmaceutical Marketing Organizations
- Launch Planning and Support for a New Formulation of an Existing Cardiovascular Product
- Launch Planning and Support for a New Respiratory Medication
- Animal Rights Action Plan Development
- Launch Planning and Support for a New Oncology Product
- Improvement of a Process to Acquire Competitive Drugs for Comparison Trials
- Refinement of a Positioning Strategy for a New HIV Medication
- Competitive Analysis to Help a Brand Team Prepare for the Launch of a New Competitor
- Scenario Planning for a Product Late in Its Life Cycle
- Advisory Boards to Address Barriers to Adoption for a New Product
- Profiling of European Advocacy Organizations
- Long-Term Care Strategy Presentation
- Selling Strategy for a Product in a Complex Market Environment
- Market Assessment for a New HIV/AIDS Drug
- Marketing Training Curriculum Design
- Launch Planning and Support for a New Oncology Product
- Hypothesized Buying Process for a New Oncology Therapy
- HIV Commercial Assessment and Portfolio Strategy
- Class Designation for a New Product
- Update of the Global Commercial Strategy for a Leading Osteoporosis Product
- Update of the Global Commercial Strategy for a Leading Oncology Product
- Assessment of the Impact of New ASCO Treatment Guidelines on Use of a Leading Oncology Therapy
- Evaluation of a Pre-Launch Brand Plan
- Support for the Global Launch of a New Oncology Product
- Global Launch Playbook (TM)
- Customization of Call Center Database to Improve Analysis Capabilities
- Review of Managed Markets Sales Team
- Commercial Assessment of a Product For Two Indications
- Review and Standardization of Launch Best Practices
- Disease State Training Program Development and Facilitation
- Management of Company-Wide Launch Preparation Activities
- Specialty Pharmacy Distribution Strategy
- Practice Management Strategy
- Development and Management of Launch Playbook
- Development of Post Launch Product Strategy
- Development of Strategies to Address Barriers to Adoption
- Market Assessment to Prepare for Product Launch
- Development of Comprehensive Commercial Plan
- Development of Commercial Strategy
- Developed SOPs For Thought Leader Management Activities
- "Launch Playbook" To Guide Launch Activities
- Manual of Commercial Best Practices
- Revenue Forecasts for Two Pharmaceutical Products
- Development and Management of a Brand Strategy Summit Meeting
- Launch Playbook For Product Launch in US and Europe
- Strategic Plan Review
- OTC Product Assessment
- Strategic Plan Development For US Product Launch
- European Commercial Strategy for a New Extended-Dosage Form of an Existing Product
- Commercial Strategy for a New Oncology Product
- Process Improvement for a Leading Pharmaceutical Company's Marketing Operations Department
- Expansion and Restructuring of a Leading Biotech's Commercial Support Organization
- Improvement of Sales Performance in an Under-Performing Sales Region
- Development of a Selling Model for a Specialized Pre-Launch Product
- Commercial Opportunity Assessment and Strategic Planning to Guide Development of a Phase III Dermatology Product
- Pricing Strategy for an Orphan Drug
- Comprehensive Commercial Planning for a New Biotech Product
- Commercial Planning for a Pre-Launch Product
- Stratgy to Help a Leading Product Penetrate the In-Patient Market
- Improvement of Commercial Planning Processes for a Leading Biotech Firm
- Comprehensive "Launch Playbooks"
- Update of a Successful Selling Strategy
- Strategy to Maximize the Uptake of a Recently Launched Brand
- Development Strategy for a Medical Device/Drug
- Unified Strategic Planning Process for a Biologic That Was Marketed in Numerous Therapeutic Areas
- Development of a "Disease Dossier" to Inform Commercial Planning
- Planning for a Product Launch in the EU
- Strategy to Help a Client Wrest Market Share From An Established Competitor
- Development and Updating of a Global Commercial Plan
- Market Research to Inform the Commercial Strategy for a New Oncology Product
- Successful Launch Planning and Execution
- Strategy to Turn Around an Underperforming Product
- Strategy Summit for a Recently Launched, Potential "Blockbuster" Product
- Strategy to Enhance the Commercial Performance of a Potential "Blockbuster"
- Long-Term Commercial Strategy for a New Oncology Product
- Life Cycle Management Strategy
- Comprehensive "Launch Playbook" to Ensure the Successful Launch of a New Biotech Product
- Assessment of the Market Potential of a New Product Combining Two Diabetes Medications
- Business Plan for a Nephrology Drug's Potential Entry into the Assisted Living Facility Market Segment
- Pre-Launch Planning and Project Management Assistance
- Pre-Launch Logistical Planning
- Critical Assistance to a Pharma-Focused Advertising Agency
- Assessment and Prioritization of Potential New Indications for a Marketed Product
- Competitive War-Gaming to Help Refine the Brand Strategies for Two Leading Products
- Comprehensive Enhancement of a Biotech Firm's Commercial Organization
- "Launch Playbook" Development for a Phase III Product
- Comprehensive Launch Planning for a New Oncology Product
- Business Case to Assess the Commercial Opportunity Associated with a New Dosing Schedule for an Established Brand
- Assessment of the Opportunity Associated with a New Indication for a Marketed Product
- Development of a Pricing Strategy
- Generic Defense Strategy
- New Market Opportunity Assessment for a Healthcare IT Firm
- Establishment of a Marketing Excellence Program for a Mid-Sized Biotech Firm
- Analysis of a Leading Pharmaceutical Firm's Human Health Portfolio to Identify Products Also Suited for the Animal Health Market
- Development of a “Shadow Brand Plan” to Help a Client Prepare for the Launch of a New Competitive Product
- Analysis of a Portfolio of Products and Recommendations for Improving ROI
- Launch Strategy and Planning for a Product in Phase III Development
- Comprehensive Brand Plan for a Product in Phase III Development
- Development of a Commercial Planning Process for the US Division of a Japanese Pharmaceutical Company
- Market Segmentation Strategy for a CNS Brand
- Assessment of a Pediatric Indication for a Global Mega-Brand
- Pricing Research for a Leading CNS Brand
- Strategic Planning for a Leading Adjunct Therapy in Oncology
- Commercial Strategy Development and Launch Planning for a Compound in Phase III Development
- Development of a Treatment Flow Model to Help Assess a New Indication for a Marketed Product
- Assessment of the Market Opportunity Represented by a New Indication for a Marketed Product
- Redesign and Enhancement of a Specialized European Development Team for a Leading Biotech Company
- Comprehensive Pre-Launch Planning for a New Pharmaceutical Product
- Market Assessment and Commercial Strategy Development for a Pre-Launch Product
- Comprehensive Market Assessment to Determine Whether a Top Biotech Firm Should Market Its Lead Product in the Critical Care Environment
- Development and Testing of a Clinical Rationale for the Use of a Marketed Product to Treat a New Indication
- Development of a System to Prioritize and Assess Potential New Indications for a Marketed Product
- Assessment of the European Market Potential of a New Indication for a Marketed Product and Development of a Commercialization Strategy
- Assessment of the Market Potential of a New Indication for a Marketed Product
- Development of a Business Case to Assess the Market Potential of a New Indication for a Marketed Product
- Development of a Business Case and Forecasts to Support the European Launch of a Biologic Product
- Market Assessment of a New Indication for a Leading Marketed Product
- Assessment of a New Indication for the European Market
- Analysis of the Impact of a New Dosing Algorithm on Product Sales
- Analysis of Sampling's ROI and Ability to Affect Prescription Decisions
- Pre-Launch Audit for a Potential Blockbuster
- Strategic Plan to Better Coordinate the Sales and Marketing Functions of a Leading Biotech Firm
- Development of a Global Commercial Plan for a Large Biotech Firm
- Enhancement of a Strategic Brand Plan
- Development of an Account Management Process for Use in the European Union
- Online Marketing Plan for a New Lifestyle Product
- Turn-Around of an Underperforming European Business Unit
- Development of a Marketing Strategy for Healthcare Communication Products
- Tactical Planning Assistance for the Marketing Team at a Diagnostic Company
- Market Potential Assessment of a Diagnostic Product at a Leading Pharmaceutical Company
- Development of Promotional Strategy for a Brand at a Leading Pharmaceutical Company
- Raynaud’s Disease Market Research for a Leading Pharmaceutical Company
- Assessment of the Commercialization Potential of an Orphan Drug for a Leading Pharmaceutical Company
- Development and Implementation of a Strategic Brand Plan for a Leading Pharmaceutical Company
- Development and Management of a Product Launch for a Leading Pharmaceutical Company
- Assessment of Potential Contracting Strategies for a Product from a Leading Pharmaceutical Company
- Development of a Health Economics Research Plan for a Leading Biotechnology Company’s Key Product
- Development of a Comprehensive Business Plan for the European Marketing Operations of a Leading Biotech Company
- Recommendations to Improve the Efficiency and Useability of a Client’s Global HIV Intranet Site
- Comprehensive Strategy and Support to Significantly Enhance the Sales of an Under-Performing Biologic Product
- Focus Group Discussion to Help a Genomics Company Explore Opportunities in Proteomics
- In-Depth Market Research for a Leading Genomics Company
- Reorganization of a “Top 10” Pharmaceutical Company’s E-Marketing Function
- Methodology to Screen and Prioritize Potential New Indications for a Biopharmaceutical Product
- Pre-Launch Strategy to Gain Early Market Share by Offering Rebates to Select PBMs.
- Development of an Innovative Selling Strategy and Training Program to Help a New Brand Steal Market Share from a Firmly Entrenched Competitor
- Market Assessment, Clinical Development, and Market Entry Strategies for a Novel CHF Therapy
- Development of a Decision-Making Tool to Help an e-Business Team Allocate Online Promotional Resources Across a Portfolio of Brands
- Web-Based DTC Strategy to Support the Launch of a New Product in a Competitive Market
- Pre-Launch Strategy for Capitalizing on Selling Opportunities in the Online Environment
- Development of an Extranet for Investigators and Key Opinion Leaders
- Web-Based Strategy to Increase Awareness Among Psychiatrists
- Development of a Suite of Web-Enabled Disease-Management Programs
- Development of a Web-Based Disease-Screening Tool for Consumers
- Facilitation of a Cross-Industry Collaboration
- Comprehensive Strategic Marketing Plan for a Healthcare Internet Company
- Evaluation of the Business Potential of a Healthcare Software Product
- Development of a Plan to Market Healthcare Informatics Products
- Combined Business Development and Marketing Strategy
- Web Strategy to Drive Increased Usage of a Non-Promoted Compound
- E-Alliance Strategy and Implementation
- Pre-Launch Strategy to Support a New Product Indication in a New Market
- Strategy to Build Competitive Advantage on the Web through Early Development of Content and Partnerships
- Web Strategy to Support Launch-Year Marketing Objectives
- Opportunity Assessment and Business Plan for a Large Pharmaceutical Outsourcing Firm
- in Order to Secure Sale of the Client
Business Development
- Market Opportunity Assessment for Oncology Assets
- Out-Licensing Document Development
- Licensing Strategy
- European Partner and Opportunity Screen
- Partnership Materials Development for Follow-On Biologics
- Follow-On Biologics Market Assessment
- Blood Factor Product Reviews
- Medical Device Market Assessment
- Co-Promotion Preparation
- Business Model Development
- Evaluation of a Potential Partner
- Deal Review
- Business Overview and Opportunity Presentation
- Market Assessment for Licensing Opportunity
- Acquisition Opportunity Review
- Product Opportunity Review
- Licensing and Acquisition Opportunity Identification
- Neuroscience Strategy
- Opportunity Review
- US Launch Playbook
- OTC Product European Launch Playbook
- Product Launch Support
- Development Structure Redesign
- Assessment and Prioritization of In-Licensing Candidates
- Cardiovascular Global Franchise Strategy
- Strategy Discussion Document Development
- Forecast Model Development
- Market Assessment
- Product Acquisition
- Compound Assessment and Out-Licensing Plan
- Opportunity Review of Oncology Compounds
- Identification and Assessment of Potential In-Licensing Opportunities
- Valuation of Potential Licensing Opportunities
- Evaluation of an In-Licensing Opportunity
- Assessment of a European In-Licensing Opportunity
- Identification of Potential Outlicensing Partners
- Preparation for Partnering Negotiations
- Development of a New Business Model for a Life Sciences Company
- Out-Licensing Strategy and Support
- Development of an Ex-US Out-Licensing Strategy
- Assessment of an In-Licensing Opportunity in Oncology
- Assessment of an In-Licensing Opportunity in Diabetes
- Assessment of an In-Licensing Opportunity in Oncology
- Out-Licensing Support for an Improved Formulation of an Existing Product
- Market Opportunity Assessment and Out-Licensing Support for a New Formulation of an Existing Product
- Market Assessment and Out-Licensing Support for an Extended Release Version of an Existing Product
- Business Model Development
- Advisory Board Preparation
- Evaluation of An Innovative Biologic for Possible In-Licensing
- Review of Terms for Possible Co-Promotion Opportunity
- Due Dilligence To Determine Commercial Opportunity
- Evaluation of Commercial Viability for Promising Compound
- Structuring of Deal Terms
- Assessment of Market Potential for Three Products
- Review of Sales and Marketing Strategies
- product In-Licensing Opportunity Assessment
- In-Licensing Opportunity Evaluation
- Evaluation of An In-Licensing Opportunity
- Built Framework For Assessing Product Development Opportunities
- Conducted A High-Level Market Forecast Covering Multiple Geographic Areas
- Market Opportunity Assessment for Partnering
- Canadian Marketplace Assessment
- In-licensing Target Identification
- Identification and Assessment of Potential Development/Commercialization Partners for a Pharmaceutical Product
- Development of US Market Entry Strategy
- CA helps a client understand the commercial issues involved with combination therapies.
- Engagement to review innovative drug delivery opportunity
- Engagement to help a leading pharma company decide whether or not to in-license a product requiring a patient assistance program.
- Opportunity Assessments Regarding a Portfolio of Four Products
- Operational Planning for the Launches of Two Products in Six European Countries
- Strategy for an Innovative Combination Product
- Preliminary Due Diligence for a Potential Product Acquisition
- Strategy to Help a European Pharmaceutical Company Enter the US Market
- Benchmarking Study Analyzing Key Strategic Methods for Entering the US Pharmaceutical Market
- Evaluation of an Acquisition Opportunity
- Outlicensing Strategy for a Promising Phase II Compound
- Assessment of the Managed Markets Environment for a Potential In-Licensing Candidate
- Identification of In-Licensing Opportunities in Men's Health
- Identification and Assessment of Potential International Outlicensing Partners for a Transdermal CNS Product
- Assessment of a Potential In-Licensing Opportunity for an Emerging Pharmaceutical Company
- Development of an In-Licensing Strategy
- Assessment of an In-Licensing Opportunity
- Assessment of the Likely Managed Markets Environment Facing a New Product Being Considered for In-Licensing
- Analysis of a Portfolio of Products and Recommendations for Improving ROI
- Market Assessment and Revenue Forecasting Model to Evaluate an In-Licensing Opportunity
- Evaluation of Licensing/Partnership Options Regarding a Potential Blockbuster
- Market Potential Assessment of a Diagnostic Product at a Leading Pharmaceutical Company
- Raynaud’s Disease Market Research for a Leading Pharmaceutical Company
- Assessment of the Commercialization Potential of an Orphan Drug for a Leading Pharmaceutical Company
- Assessment of a Pharmaceutical In-Licensing Opportunity
- Development of a Corporate Licensing Presentation
- Preliminary Due Diligence Supporting the Senior Management of a Midsize Pharmaceutical Client in its Merger and Acquisition Efforts
- Comprehensive Out-Licensing Strategy
- Strategic Process Improvement for the Business Development Function of a Pharmaceutical Company
- Comprehensive Assessment of a $600 Million Licensing Opportunity
- Assistance in Presenting a Healthcare IT Start-up to Potential Customers in the Pharmaceutical Industry
- Facilitation of Relatonships Between a Healthcare IT Client and Potential Customers in the Pharmaceutical Industry
- Facilitation of a Cross-Industry Collaboration
- Assistance in Out-Licensing Compounds
- Combined Business Development and Marketing Strategy
- Development of a Long-Term Plan to Ensure Competitiveness
- Business Analysis to Enable Client to Secure Additional Financial Support
Clinical Development
- Quality Review of ETO System Data
- Testing Consolidation
- CRO Assessment
- Sales and Marketing Blueprint
- Quality Initiative
- CTMS Support
- Identification and Managing Site Compliance
- EDC Phase I
- EDC Phase II
- Market Research
- Long-Term Care Promotional Mix Evaluation
- Clinical Drug Supply Chain Management
- Integrating Medical Writing as a Partner in Data Quality
- Ongoing Program Management Support
- CTMS Support
- ePRO Implementation
- Medical Affairs Policies
- EDC Phase III
- EDC Process Change and Support
- Strategic Solutions Group Design
- Process Improvement
- CTMS Support
- Clinical IT Project Planning
- ePRO Adoption Strategy and Supporting Processes
- Merger Discussion Facilitation
- Scientific Communications Process
- Clinical Planning System Replacement Planning
- SOP and Training Development (EDC Phase II)
- CTMS 18-Month Strategy
- EDC Process Design
- Safety System Selection
- Clinical Development Alignment
- Medical Affairs Capability Development
- Outsourcing Strategy
- Phase II EDC Implementation
- EDC Implementation
- EDC Rollout Support
- CDISC Strategy
- Process Training
- CTMS Project Assistance
- EDC Process Design
- Drive Process Improvement
- EDC Process Change and Support
- Study Start-Up SOPs
- Product Verbatim Certification
- EDC Process Design
- Organization Capabilities Assessment and Process Definition
- EDC Enterprise Adoption
- EDC Go-to-Market Strategy
- EDC Strategy and Vendor Selection Process
- EDC Process and Training Design
- EDC Training Development
- EDC Process and Training
- Development of Process and Tool to Help Decide Which Studies to Conduct Using EDC
- Development of Standardized Clinical EDC Forms and Edit Checks
- Clinical Trials Management System Standardization
- EDC Implementation
- Company Acquisition Assistance
- Development of EDC User Requirements for MeRITS
- Development of a Clinical Development Plan to Inform a Key Decision on an In-Licensing Candidate
- EDC Selection and Work Processes
- Redesign of a Data Management and Biostatistics Department
- Development of a Clinical EDC Strategy
- EDC Strategy and Vendor Selection
- Redesign of a Medical Affairs Organization
- EDC Transition Plan
- Clinical Organization Design and Clinical Process Development
- EDC Implementation
- Development of a Medical Affairs Capability
- Development of an EDC Strategy
- Clinical Electronic Data Capture (EDC) Strategy Development
- Improvement of Clinical Data Management Processes for the U.S. Army
- Implementation Support for a Clinical Electronic Data Capture (EDC) System
- Process Redesign to Facilitate Implementation of an EDC Solution
- EDC Strategy Development
- Development of a Strategy and Processes for More Efficient Clinical Outsourcing
- Strategic Planning for a Foundation to Serve the Pharmaceutical and Biotech Induustry
- Review of Global EDC Strategy One Year Following Implementation
- Revision of Clinical Strategy to Support EDC
- Development of SOPs for Clinical Processes
- Conducted Industry IRG Policies Benchmarking
- Developed EDC Commercial and Operational Strategies
- Built Contracting Strategy
- Developed Global EDC Training Methods
- Developed High-Level Product Development Plan
- Assessed Clinical Operations Infrastructure
- Development and Implementation of a System to Track Laboratory and Imaging Data from a Large Clinical Trial Program
- Benchmarking Study to Help Optimize a Client's Program for Investigator-Initiated Studies
- Operational Planning for Clinical Development of a Promising New Compound
- Development of Processes to Avoid Patient Recruitment Delays
- Program to Enhance Clinical Site Relationships and Patient Recruitment
- Process to Help a Large Hospital System Develop and Implement New Healthcare Programs
- Streamlined Process for Evaluating and Comparing Various CRO Project Bids
- Research to Help Plan the Implementation of a Clincal eDM System for a Top-Ten Pharmaceutical Company
- Development of Process Maps to Increase the Efficiency of a Leading Biotech's Clinical Development Organization
- Development of a Publication Planning Strategy for a Major Biotech Firm
- Development of a Comprehensive R&D Strategy for the US Division of a Major Japanese Pharmaceutical Company
- Development Plan to Expand a Small Pharmaceutical Company's Clinical Development Organization
- Organizational Improvement for a Mid-Sized Pharmaceutical Company's Clinical Development Organization
- Leadership of Worldwide Process Redesign in Support of New EDM Tool
- Development of Organizational Structure and Processes for a Medical Communications Department
- Analysis of Reported Adverse Events During a Clinical Trial
- Development and Management of a Patient Recruitment Program for a Leading Pharmaceutical Company
- Innovative Strategy and Web-Based Program for More Effectively Identifying, Selecting, and Managing Outsourcing Partners for Clinical Development Activities
- Design of the Clinical Development Function of a Midsize Pharmaceutical Company
- Creation of a Comprehensive Clinical Development Strategy for a Compound
- Strategic Decision Support for a Leading CRO on the Development of Web-Based Data Collection and Management Tools
Managed Markets
- Part D Formulary Tracker
- Post-Trial Research
- Home Cholesterol Assessment Phase II
- Cholesterol Test Tech Assessment
- Hospital Market Assessment
- Market Assessment
- Managed Markets Environment Dynamics
- Employer Opportunity Assessment
- Employer Channel Assessment
- Payer and Distributor Segmentation Analyses
- Antipsychotic Product Reimbursement Analysis
- Transplant Product Reimbursement Project
- Channel Strategy
- Product Pricing Assessment
- Customer Strategy
- Lifecycle Strategy
- Product Pricing Strategy
- Customer Strategy
- Managed Markets Account Assessment and Alignment
- Contracting Strategy Update
- Pricing Strategy
- Managed Markets Launch Strategy and AMCP Dossier
- Payer Assessment
- Evaluation of a Contracting Strategy
- Managed Markets Launch Strategy
- Managed Markets Training Development
- End-of-Lifecycle Strategy Development
- Payer Market Assessment
- Managed Markets Training Day
- 100-Day Plan
- Marketing Tool Development
- Performance Measurement Strategy
- Comprehensive Managed Markets Strategy Development
- Competitive Strategy Development
- Contract Strategy Development
- Allergy Immunotherapy Market Assessment
- Revamp of Training Programs for the Contracts and Pricing Group at a Leading Company
- Payer Research for a Pre-Launch CNS Product
- Conduct of Primary Research with Payers to Inform Development of Improved Patient-Focused Programs
- Development of a Pricing and Contracting Decision Support Model
- Redesign of Managed Markets Communication and Data Management Processes
- Understanding an Increasingly Challenging Reimbursement Environment
- Pricing-Related Assistance
- Oncology Product Positioning within the Medicare Formulary
- Assess and Improve Managed Markets Structure, Role, Responsibilities, and Processes
- Understanding the Reimbursement and Distribution Environment of Critical Care Products
- Understanding the Pre-Diabetic Market
- Managed Markets Business Group Assessment
- New Indication Launch Planning
- Brand Re-Launch
- Assessment of a Managed Markets Account Management Force
- Development of a Managed Markets Launch Plan
- Development of a Payer Value Proposition for a Pre-Launch CNS Product
- Development of a Reimbursement and Access Strategy
- Medicare Part D Readiness Diagnostic
- Medicare Part D Strategic Plan for 2007
- Long-Term Care Strategy
- Payer Research for a Pre-Launch Gastrointestinal Product
- Analytical Assessment of Pricing Decisions for a Portfolio of Biotech Products
- Pricing Strategy for a Portfolio of Products
- Payer Research for a Pre-Launch CNS Product
- Payer Research for a Branded Generic CNS Product
- Medicare Part B CAP Strategy for an Established Product
- Research to Understand the Impact of Medicare Part D on the Long-Term Care Strategy for an Established Product
- Pricing and Contracting Strategy for a Pre-Launch Product
- Managed Markets Channel Assessment for a Pre-Launch Endocrine/Metabolism Product
- Employer Channel Assessment
- Assessment of Changes in the Payer Environment Regarding Management of a Specific Class of Products
- Managed Markets Contracting Research
- Pricing Scenario Planning
- Development of a Managed Markets Channel Strategy
- Research to Develop a Canadian Reimbursement Strategy
- Long-Term Care Strategy Presentation
- Managed Markets Channel Assessment for a Pre-Launch Product
- Managed Markets Channel Assessment and Strategy
- Comprehensive Managed Markets Contracting Strategy
- Contracting Strategy for a New Antibiotic
- Assessment of How Payers Would React to Enhanced Delivery Systems for Existing Products
- Managed Markets Account Segmentation and Contracting Strategy
- Pricing and Contracting Strategy for a Pre-Launch Cardiovascular product
- Pricing Strategy for a Pre-Launch Brand
- Scenario Planning for Medicare Part D
- Presentation Detailing the Managed Markets Launch Plan for a New Product
- Assessment of the Changing Reimbursement and Access Situation for a Leadng Product
- Payer Research for an Extended Release Version of an Existing Product
- Part D Market Assessment for a Blockbuster Product
- Systematic Approach to Developing Medicare Part D Strategies
- Pull-Through Training Program
- Pull-Through Strategy and Process
- Training Session in Strategic Planning
- Primary Research to Inform Managed Markets Contracting Terms
- Evaluation of Contracting Strategies For Five Leading In-Line Products and Two Pre-Launch Products
- Part D Formulary Tracker Development
- Programs to Improve Patient Outcomes and Compliance
- Assessment of Medicare Environment To Inform Sales Training
- Competitive Acquisition Program (CAP) Overview To Enable Strategic Planning
- Diabetes Market Assessment For Novel Delivery Device
- Value Proposition to Ensure Optimal Formulary Positioning
- Federal Markets Strategy Revision
- Competitive Assessment to Prepare for Product Launch
- Part D Formulary Tracking Tool
- Research to Assess the Impact of Medicare Part D On a Product Portfolio
- Analytical Support To Guide Strategic Planning For Medicare Part D
- Research to Prepare for MMA's Competitive Acquisition Program
- Assessment To Prepare For New Contracting Environment
- Market Assessment To Inform Product's Medicare Strategy
- Managed Markets Advisory Board Development
- Product-Specific Medicare Strategy Development
- Pricing Assessment to Protect Revenue
- Conducted Market Assessment to Prepare for Medicare Part D
- Developed Medicare Strategies Across Entire Product Line
- Developed Hospital Pricing Strategy
- Developed Managed Markets Situation Assessment
- Developed Pull-Through Strategy
- Trained Senior Executives on Managed Care
- Developed a Managed Markets launch Strategy
- Contracting Strategy Development
- Value Proposition Strategy Development
- Medicare Part D Strategy
- Developed Comprehensive Federal Markets Strategy
- Developed Medicare Part D Access Strategy
- Medicare Part D Contracting Strategy
- Development of a Series of Managed Markets Account Management Presentations
- Medicare Strategy for a Top 20 Pharmaceutical Company
- Global Reimbursement Plan Development
- Research to Enhance Uptake and Acceptance of a New Formulation for a Hospital-Based Product
- Strategy to Help a Leading Pharma Company Make Better Use of Data on the Relationship Between Co-Pay Level and Product Utilization
- Managed Markets Strategies for a Portfolio of Products
- Hospital Strategy for a New Product
- Pull-Through Strategy and Tools for a Blockbuster Product
- Project to Determine Medicare Part D's Implications for a Leading CNS Product
- Research on Payer Attitudes Toward a Potential New Delivery Method for an Existing Product
- Managed Markets Strategy for an Injectable Product in a Highly Competitive Environment
- Web-Based Managed Care Advisory Boards
- Primary Research to Guide Development of Disease Management Programs for a Pre-Launch Product
- Comprehensive Consulting Study of the Reimbursement Environment for Anti-Depressants
- Managed Markets Primary Research Regarding a Development-Stage Combination Product
- Pull-Through Strategy and Process Development
- Managed Markets Account Management Plan of Action (POA)
- Assessment of MCOs' Likely Stance Toward a Medication Designed to Rescue Victims of a Terrorist Attack Involving Nerve Agents
- Assessment of a Potential New Service Offering for a Leading CSO
- Assessment of a New Indication for a Currently Marketed Product
- Product-Specific Financial Modeling to Understand the Implications of the Medicare Modernization Act (MMA)
- Market Assessment for Transdermal Formulations of Nine Currently-Marketed Products
- Research on the Development of Value-Added Programs for Employers
- Assessment of Managed Care's Receptivity to Developing Care Management Programs Directly with Pharmaceutical Companies
- Assessment of Opportunities Associated with Delivery of Nine Marketed Products via a Transdermal Patch
- Project to Integrate the Managed Markets Strategies of Two Merged Firms
- Value Proposition Development for Two CNS Products
- Managed Markets Research for a CNS Product
- Pricing Research and Guidance for a Pre-Launch Oncology Product
- Pre-Launch Managed Markets Strategy
- Benchmarking Study and Primary Research to Help a Client More Effectively Use Health Economics and Outcomes Research
- Development of an Enhanced Managed Care Pull-Through Strategy
- Product-Specific Medicare Strategy and Forecast
- Design and Development of a Managed Markets and Trade Infrastructure
- Assistance Responding to Draft Model Guidelines for Development of Medicare Part D Formularies
- Process to Proactively Monitor the Marketplace for Potential Generic Competitors
- Research to Improve Forecasting for a New Product
- Managed Markets Launch Strategy for a Modified Release Version of an Established Product
- Financial Modeling to Assess the Potential Impact of the Medicare Modernization Act on a Leading Pharma Company's Portfolio
- Medicare Strategy for a Top 10 Pharmaceutical Company
- Assessment of the Managed Markets Environment for a Potential In-Licensing Candidate
- Managed Markets Research and Strategy Development for a New Diagnostic Product
- Training to Help Sales Reps and Account Managers Better Handle Managed Markets-Related Challenges
- Managed Markets Research to Guide Strategic Planning for a New CNS Product
- Assessment of the Likely Managed Markets Environment Facing a New Product Being Considered for In-Licensing
- Managed Care Research and Strategy for a Cardiovascular Product
- Managed Markets Research and Strategy for a Pre-Launch CNS Product
- Research into How the Long-Term Care Market Would Respond to the Launch of a New Treatment for Overactive Bladder
- Comprehensive Medicare Strategy for a Top-Five Pharmaceutical Company
- Comprehensive Strategy for Dealing With the Medicare Prescription Drug Benefit
- Early Assessment of the Impact of the Medicare Prescription Drug Benefit on a Top-Five Pharmaceutical Company's Business
- Improvement of a Biotech Firm’s Managed Care Contracting Practices
- Primary Research to Test and Improve a New Product’s Value Proposition for Managed Markets Customers
- Identification of Critical Success Factors for a New Program to Provide Reduced-Price Drugs to Elderly Patients
- Analysis of the Impact of a New Dosing Algorithm on Product Sales
- Managed Markets Strategy for a Pre-Launch Product
- Comprehensive Consulting Study of the Reimbursement Environment for Antihypertensives
- Research to Help a Small Pharmaceutical Company Understand the Managed Markets Environment Facing its Product
- Primary Managed Care Research to Support a Launch Product
- Primary Market Research to Inform Development of a Managed Markets Strategy
- Primary Market Research to Refine a Managed Care Strategy
- Primary Managed Care Market Research
- Managed Care Advisory Boards
- Managed Care Advisory Board
- Benchmarking to Improve Pull-Through Effectiveness
- Assessment of the Market Potential of a New Managed Markets Customer Segment
- Managed Care Strategy for a Unique New Product
- Comprehensive Managed Care Pull-Through Strategy
- Improvement of Managed Care Strategies for an Entire Product Portfolio
- Development of a Customer Service Improvement Plan at a Diagnostic Company
- Market Potential Assessment of a Diagnostic Product at a Leading Pharmaceutical Company
- Development of a Managed Markets Organizational Design for a Leading Pharmaceutical Company
- Customized Training for Managed Markets Team at a Leading Pharmaceutical Company
- Benchmarking of a Managed Markets Organization at a Leading Pharmaceutical Company
- Restructuring of a Managed Markets Marketing Unit at a Midsize Pharmaceutical Company
- Managed Care Market Research on Antidepressants for a Midsize Pharmaceutical Company
- Development of a Model to Prioritize Federal Markets Accounts for a Midsize Pharmaceutical Company
- Managed Care Market Research for Arthritis Medication at a Leading Pharmaceutical Company
- Development of a Field Sales Managed Markets Resource Kit for a Leading Pharmaceutical Company
- Development of Account Manager Presentation for a Leading Pharmaceutical Company
- Development of Plans to Improve Existing, Highly Successful Disease Management Programs
- Sizing and Alignment of a Managed Markets Account Management Force
- Calculation of the Business Potential Represented by a Client’s Regional Managed Markets Customers
- Formulation of a Rationale for Building a New Tool to Capture Strategic Market Data
- Organizational Design for a Market Research Group at a “Top Five” Pharmaceutical Company
- Development of a Comprehensive Strategy to Switch Physicians and Patients from an Older Product Facing Generic Competition to a New, Improved Product
- Development of a Comprehensive Women’s Health Disease Management Program
- Analysis of the Reimbursement and Access Environment for a Branded Biological Product
- Development and Implementation of a Comprehensive Managed Care Strategy for a Potential Blockbuster Product
- Pre-Launch Strategy to Gain Early Market Share by Offering Rebates to Select PBMs.
- Strategic Enhancement of a Program of Respiratory Disease Management Services
- Development of a Strategy Enabling a Pharmaceutical Company to Better Demonstrate the Value of its Products
- Managed Care Strategy to Ensure Formulary Acceptance and Compress "Time to Peak Sales"
- Process Improvement for a Managed Care Sales Force
- Use of Primary Managed Care Market Research to Help Develop an Overall Strategy
- Development of Metrics to Assess and Improve Support of Managed Care Operations
- Managed Care Strategy to Increase Product Acceptance and Market Share
- Evaluation of a Proposed Development Project
- Comprehensive Reimbursement and Access Strategy
Operations Improvement
- Review of Global EDC Strategy One Year Following Implementation
- Customization of Call Center Database to Improve Analysis Capabilities
- Process to Help a Large Hospital System Develop and Implement New Healthcare Programs
- Research to Help Plan the Implementation of a Clincal eDM System for a Top-Ten Pharmaceutical Company
- Implementation and Training for an Improved Account Management Process
- Development of New Account Management Processes for the European Division of a Leading Biotech Firm
- Comprehensive Planning to Upgrade the CRM and Enterprise Distribution Systems for a Specialty Pharmaceutical Distributor
- Development of a Publication Planning Strategy for a Major Biotech Firm
- Development Plan to Expand a Small Pharmaceutical Company's Clinical Development Organization
- Organizational Improvement for a Mid-Sized Pharmaceutical Company's Clinical Development Organization
- Leadership of Worldwide Process Redesign in Support of New EDM Tool
- Development of Organizational Structure and Processes for a Medical Communications Department
- Design and Development of a Medical Affairs Department
- Development of an Account Management Process for Use in the European Union
- Benchmarking of a Managed Markets Organization at a Leading Pharmaceutical Company
- Restructuring of a Managed Markets Marketing Unit at a Midsize Pharmaceutical Company
- Development and Management of a Patient Recruitment Program for a Leading Pharmaceutical Company
- Formulation of a Rationale for Building a New Tool to Capture Strategic Market Data
- Creation of a Comprehensive Project Management Toolbox for a Key Internal Group at a “Top Five” Pharmaceutical Company
- Development and Implementation of Key Processes and Capabilities for an Internal Group at a “Top Five” Pharmaceutical Company
- Organizational Design for a Market Research Group at a “Top Five” Pharmaceutical Company
- Analysis of the Marketing Benefits of Offering Physicians a Free Software Program
- Reorganization of a “Top 10” Pharmaceutical Company’s E-Marketing Function
- Innovative Strategy and Web-Based Program for More Effectively Identifying, Selecting, and Managing Outsourcing Partners for Clinical Development Activities
- Development of a Suite of Web-Enabled Disease-Management Programs
- Development of a Project Management Master Plan to Coordinate the Commercialization Activities of a Leading Biotech Company
- Implementation of a CRM Technology Solution for a Leading Managed Care Sales Force
- Strategic Process Improvement for the Business Development Function of a Pharmaceutical Company
- Strategic Planning and Organizational Development for a Global Bioinformatics Business Unit
- Comprehensive Process Improvement for a Leading Pharmaceutical Company
- Centralization of Project Management Processes for a Leading CRO
- Development of a Project Management Toolbox for a Major CRO
- Creation of Project Management Processes to Facilitate the Development of a New Web-Based Tool
- Development and Implementation of a Knowledge Management Strategy
- Alignment of a Client's Processes, Structure, and Technology with Business Strategy
- Reorganization of Sales Forces within a Major Pharmaceutical Company
- Process Improvement for a Managed Care Sales Force
- Development of Metrics to Assess and Improve Support of Managed Care Operations
Pharmaceutical IT Strategy
Research and Discovery
- Implementation of Significant Process Improvement Initiative in Discovery Research
- Long-Term Strategy to Anticipate and Prepare for Market Changes Related to Pharmacogenomics
- Development of an E-Diagnostic Tool for the Genomics Diagnostics Group at a Leading Pharmaceutical Company.
- Strategic Planning Regarding Diagnostic Opportunities in Genomics
- Identification of Business Opportunities Related to Genomics
- Strategic Planning and Organizational Development for a Global Bioinformatics Business Unit
Sales
- Marketing Training Program Implementation
- Director Summit Content Development
- Integration Project Management and Business Process Recommendation
- Sales and Marketing Strategy
- Oncology Product Sales Strategy
- Product Sales Model
- District Manager Modularization
- Marketing Excellence Facilitation
- US Managed Markets Sales Force Restructuring and Alignment
- Sales Force Effectiveness Competitive Benchmark Study
- Product Readiness Plan
- Product Knowledge Certification
- DM Effectiveness Initiative
- Comprehensive Sales Strategy
- Managed Markets Account Assessment and Alignment
- Neurosciences Simulation Based Training
- POA Meeting Management
- Leadership Priorities Training
- Simulation-Based Trainings
- Sales Force Primary Research on Selling and Coaching Models
- Customized Sales Training Design and Implementation
- Product Launch Training Plan
- Managed Markets Team Resource Allocation and Alignmen
- Sales Assessment and Training
- Training and Development Strategic Alignment
- Training Strategy and Structure
- Sales Force Strategy
- Sales Strategy
- Neurology Sales Force Alignment
- Role-Specific Training Continuums
- Account Manager Training Continuum
- Marketing University Phase I
- Launch ISA
- Sales Leadership Support Rollout
- Sales Training Dashboard
- Follow-Up Interactive Selling and Coaching Assessment
- Selling Skills Certification for New Indication
- Leadership Summit and Difficult Conversations Workshop
- Market Softening Plan
- Selling Process Pull-Through Training
- District Manager Training Continuum Design
- Sales Excellence Initiative
- Hospital Sales Force Simulation-Based Training Event
- ISA for Expanded Product Indication
- Leadership Development Strategy
- Sales Force Strategy
- Advanced Training Redesign
- Management Development Candidate Program
- New Hire Enhancement
- Sales Force Skills Assessment
- TOP GUN
- Manager Leadership Summit
- Selling City Program
- Sales Force Assessment Initiative
- Sales Force Effectiveness Assessment
- Sales Impact Analysis
- Benchmarking Analysis
- Sales Force Optimization
- Managed Markets Training Day
- Sales Force Expansion and Launch Training Plan
- Advisory Board Facilitation
- Product Launch Sales Strategy
- Selling Skills Assessment to Prepare for Competitor Launch
- Simulation-Based Training to Prepare for Competitor Launch
- Selling Model Development
- Product Partnership Selling Model Implementation
- Coaching Documentation Workshop
- Product Core Message Certification
- Assessment of New Sales Representative Selling Skills
- Portfolio Call Certification
- Neurology Sales Force Alignment
- Sales Certification Assessment Process
- Field Force Expansion Program Support
- Sales Management Coaching Skills Workshop
- Sales Force Selling Model Design
- Sales Force Interactive Selling Skills Workshop
- Regional Sales Directors Coaching Continuum
- Understanding Sales Force Effectivness Through Interactive Sales Assessments
- Selling Discipline Training Continuum
- Developing Sales Training Strategic Roadmap
- Product Segmentation Strategy for Key Stakeholders
- Sales Force Skills and Capabilities Assessment
- Sales Force Alignment Strategy and Powers Team Implementation
- Training Operations Planning Support
- Sales Training Department Strategy for Anticipated New Product Approvals
- Executive Committee Training Presentation
- Sales Training Organization
- Field Leadership Meeting Planning
- Sales Force Real Play Certification
- Sales Force Training Continuum for Selling Skills Evaluation
- Field Readiness Plan for Product Launch in Expanded Indication
- Oncology Sales Strategy Development
- Strategic Options to Defend Against Generic Threat
- Revamp of Training Programs for the Contracts and Pricing Group at a Leading Company
- Training Enhancement for Medical Science Liaisons
- Primary Care Sales Training Program Enhancement
- Development of Training Program for District Trainers
- Marketing Manager and Director Training
- Marketing Manager and Director Training
- Marketing Manager and Director Training
- Market Change Assessment
- Medical Science Liaison Training
- DM Training Program
- Development of Segmentation Options
- Define Value Offerings and Develop Communication Plan for Leading Biotech.
- Speaking and Presentation Skills Improvement
- Development of On-Boarding Program for Sales Trainers
- District Manager Training Programs
- Sales Training Project Management Plan
- Sales Target Refinement
- International Sales Manager Training Workshop
- Comprehensive Training Program for Managed Markets Account Managers
- DSM Structured Training Curriculum
- Improvement of Sales Force Effectiveness
- Implementation Support for Initial Rep Training Enhancements
- Comprehensive Revamp of the Sales Strategy and Operations at a Small Pharmaceutical Company
- Recommendations to Improve the Effectiveness of Training Programs for Sales Reps and Managers
- Sales Training Support for Two Marketed Products
- Training Program to Prepare Sales Reps for the Launch of a New Indication for a Marketed Product
- Assessment and Training Program for Sales Managers and Representatives
- Sales Management Training and Development Program Design
- Development of a Selling Model and Sales Training Program
- Sales Strategy for a New HIV Therapy
- Selling Process Design and CRM Re-Launch
- Design and Development of a Commercial Infrastructure
- Development of a Marketing Training Program
- Selling Strategy for a Product in a Complex Market Environment
- Specialty Sales Force Training Enhancement
- Program to Improve Key Account Management Processes
- Design of a District Sales Manager Development Program
- Marketing Training Curriculum Design
- Enhancement of an Initial Sales Rep Training Program
- SOPs for a Leadership Development Program
- Sales Strategy for a Portfolio of Products
- Institutional Sales Strategy for Two Acute Care Products
- Development of a New Business Planning Process
- Assessment of Sales Organization Size and Structure
- Training Program to Support and Facilitate Changes in DSM Role
- Research To Determine Product Sampling and Prescribing Rate Correlation
- Incentive Compensation Vendor Oversight
- Development of Innovative Sales Strategies to Support Product Launch
- Development of Collateral to Support New Selling Model Roll Out
- Redesign of Sales Training and Development Program to Focus on Growing Internal Leaders
- Development of a Sales Strategy to Target Academic Institutions
- Developed Sales Force Alignment and Implementation Plan
- Developed Sales Strategy
- Assessed Sales Force Targeting Methods
- Assessment and Restructure of Sales Force
- Redesign of a Leading Pharmaceutical Company's Sales Leadership Training Program
- Implementation of a New Sales Training Program
- Improvement of Sales Force Effectiveness
- Development of a New Process to Conduct Regular Assessments of Sales Rep Capabilities
- Selling Model Development
- Implementation of a New Sales Rep Training Program for a Top-Five Pharma Company
- Improvement of Sales Performance in an Under-Performing Sales Region
- Integration of Two Pharmaceutical Sales Forces Following an Acquisition
- Restructuring of a Leading Pharmaceutical Company's Sales Support Organization
- Development of a Selling Model for a Specialized Pre-Launch Product
- Design and Development of a Sales Training Infrastructure
- Comprehensive Review and Enhancement of a Leading Pharmaceutical Company's Sales Force
- Sales Force Optimization
- Update of a Successful Selling Strategy
- Rollout and Training for a Top-10 Field Sales Force's New Business Planning Process
- Strategic Plan to Help a CSO Maintain its Leading Market Position
- Promotional Optimization for the Branded Division of a Generics Manufacturer
- Development of a Process and Tools to Realize Maximum Value from CSO Relationships
- "Build or Buy" Decision for an Incentive Compensation Administration System
- Assessment and Improvement of the Incentive Compensation Program for an Oncology Sales Force
- Sales Force Intelligence Initiative to Identify and Address Challenges Faced by a CSO Sales Force
- Comprehensive Program to Identify and Improve Under-Performing Sales Reps
- Development of a New Sales Business Planning Process
- Sales Strategy for a Pre-Launch Injectable Biologic Product
- Strategic Plan for a Leading Pharmaceutical Company's Institutional Sales Force
- Analysis and Optimization of a Small Pharma Company's Entire Sales and Sales Support Organization
- Strategy for Improving the Performance of a Mid-Sized Companies Women's Health Division
- Size, Structure, and Alignment for a Leading Biotech's European Sales Forces
- Strategic Analysis of the Future Selling Environment for Primary Care Sales Forces
- Size, Structure, and Alignment for a New Sales Force Operating in a Difficult Market Environment
- Blueprint of the Complete Sales Infrastructure for a Small Pharmaceutical Company
- Interactive Sales Assessment of the Sales Force for a World-Leading Product
- Analysis of Sampling's ROI and Ability to Affect Prescription Decisions
- Interactive Sales Assessment of Sales Forces for a Company's Lead Product
- Strategic Plan to Better Coordinate the Sales and Marketing Functions of a Leading Biotech Firm
- Implementation of Improvements to an Initial Sales Rep Training Program
- Assessment and Improvement of the Sales Training Program for a "Top 10" Pharmaceutical Company
- Comprehensive Improvement of District Sales Manager Training Programs
- Interactive Sales Training for the Launch of a New Indication
- Interactive Sales Assessment for Two Specialty Sales Forces
- Development and Implementation of a New Sales Training Function
- Identification of Opportunities to Enhance Sales Training at a “top 10” Pharmaceutical Company
- Implementation of Sales Training Enhancements
- Interactive Sales Assessment of New Sales Team at a Leading Pharmaceutical Company
- Implementation of Enhancements to the Sales Training Organization of a “Top 10” Pharmaceutical Company
- Benchmarking, Needs Assessment, and Solution Development for the Sales Training Function of a Leading Pharmaceutical Company
- Sizing and Alignment of a Managed Markets Account Management Force
- Development of Recommendations for Streamlining Sales Training Through Automation
- Refinement and Implementation of a Training Program for New Pharmaceutical Sales Reps
- Development and Implementation of a Major Market Research Effort
- Interactive Sales Assessment to Test the Field-Readiness of the 160-Person Sales Force for a Diagnostic Product
- Interactive Sales Assessment to Prepare a Leading Biotech’s Sales Force for an Impending Product Launch
- Interactive Sales Assessment for Launch of a New Indication for an Established Biologic Product
- Evaluation of the Effectiveness of a 100-person HIV Sales Force for a Major Pharmaceutical Company
- Development of a Statistical Model to Improve Recruitment of Sales Representatives
- Benchmarking Study and Needs Assessment for the Sales Training Function of a Leading Pharmaceutical Company
- Development of an Innovative Selling Strategy and Training Program to Help a New Brand Steal Market Share from a Firmly Entrenched Competitor
- High-Intensity Sales Training in Preparation for a New-Product Launch
- Reorganization of Sales Forces within a Major Pharmaceutical Company
- Process Improvement for a Managed Care Sales Force
Strategic Planning
- Strategic Planning for a Foundation to Serve the Pharmaceutical and Biotech Induustry
- Training Session in Strategic Planning
- Strategic Assessment of a Service's Viability for Use in the Pharmaceutical Industry
- Strategic Plan to Help a Company Determine How Best to Serve Pharmaceutical Customers
- Development of Operating Plan and Budget for the European Division of a Leading Biotech
- Enhancement of a Strategic Brand Plan
- Tactical Planning Assistance for the Marketing Team at a Diagnostic Company
- Development of a Comprehensive Business Plan for the European Marketing Operations of a Leading Biotech Company
- Development of a Detailed Business Plan for a Key Internal Group at a Leading Pharmaceutical Company
- Comprehensive Out-Licensing Strategy
- Development of Investor Relations Materials for Early-Stage Biotech Companies
- Enhancement of Investment Community Outreach Materials
- Development of an E-Diagnostic Tool for the Genomics Diagnostics Group at a Leading Pharmaceutical Company.
- Strategic Planning Regarding Diagnostic Opportunities in Genomics
- Identification of Business Opportunities Related to Genomics
- Development of an E-Business Strategy for a Physician Practice Management Company
- Development of an Overall E-Business Strategy for a "Top Five" Pharmaceutical Company
- E-Business Strategy Development and Implementation Support for a Biotech Firm
- Development of a Strategy Enabling a Pharmaceutical Company to Better Demonstrate the Value of its Products
- Opportunity Assessment and Business Plan for a Large Pharmaceutical Outsourcing Firm
- Review and Improvement of an Existing Business Plan
- Development of a Long-Term Plan to Ensure Competitiveness
- Evaluation of Strategic Alternatives
- in Order to Secure Sale of the Client
- Business Analysis to Enable Client to Secure Additional Financial Support
- Identification and Evaluation of Opportunities in a New Market
- Assessment of Potential Market Opportunities
- Identification of New Market Opportunities
- Strategic Planning and Organizational Development for a Global Bioinformatics Business Unit
- Long-Term Strategy for International Operations
- Alignment of a Client's Processes, Structure, and Technology with Business Strategy
Trade and Distribution